BioTrinity 2022 is only a couple weeks away! Medicilon is excited to attend and exhibit at the conference. Our Vice President and Business Development team will be exhibiting at the conference. We are happy to meet you in person to discuss how our services and capabilities would support your current research needs and expedite your drug discovery and development programs. We look forward to seeing you soon and wish you safe trips!
BioTrinity 2022 集行業(yè)之聲，讓中國醫(yī)藥界感知 BioTrinity 的新訊息。美迪西很高興能參加此次BioTrinity 。我們歐洲團(tuán)隊(duì)將出席此次會(huì)議。我們期待與您會(huì)面并討論美迪西的強(qiáng)大服務(wù)能力將如何支持您的研發(fā)需求，并加快您的藥物研發(fā)！
Date: April 26-27, 2022
Location: England, United Kingdom
ABOUT BioTrinity 2022何為BioTrinity？
BioTrinity is an established, must-attend London conference, that catalyses growth and supports in-person re-engagement across the life sciences industry. The event is attended by an audience of early stage and emerging life sciences R&D Companies, investors, big pharma, and other valued partners throughout the life sciences ecosystem. The conference features a focused, relevant, and stimulating programme, led by great speakers, who bring their knowledge, expertise, and vision to the fore in exciting, high-quality sessions.
? 這是一次生命科學(xué)行業(yè)的面對(duì)面深度會(huì)談。參加此次活動(dòng)的有早期和新興生命科學(xué)研發(fā)公司、投資者、大型制藥公司和整個(gè)生命科學(xué)生態(tài)系統(tǒng)中的其他重要合作伙伴。江山代有人才出，由眾多的優(yōu)秀演講者帶來新技術(shù)的分享！
? 七個(gè)核心治療領(lǐng)域——腫瘤學(xué)、中樞神經(jīng)系統(tǒng)、微生物組、炎癥、罕見病、傳染病以及人工智能和數(shù)據(jù)。
Innovative Drug R&D Services創(chuàng)新藥研發(fā)服務(wù)
Medicilon is an integrated contract research organization (CRO), providing comprehensive one-step new drug R&D for pharmaceutical enterprises and scientific research institutions around the world. We provide one-stop customized R&D solutions ranging from precise drug targeting to IND filing assistance.Deeply integrate R&D experience, constantly climb the peak of R&D technology, and build an integrated innovation service platform for new drug R&D.
Innovative Drug R&D Services
? Antibody-Drug Conjugate(ADC) R&D project
? PROTAC Drug Discovery Research Platform
? mRNA Vaccine Bioanalysis Platform
? Non-clinical Research for Cellular Immunotherapies
美迪西深度整合研發(fā)經(jīng)驗(yàn)，不斷攀登研發(fā)技術(shù)高峰，搭建新藥研發(fā)一體化創(chuàng)新服務(wù)平臺(tái)：
? ADC臨床前研發(fā)項(xiàng)目
? PROTAC 藥物發(fā)現(xiàn)技術(shù)平臺(tái)
? mRNA疫苗生物分析技術(shù)平臺(tái)
? 細(xì)胞免疫治療藥物平臺(tái)等
相關(guān)新聞
